Zhihong Wang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

40-Week Repeat-Dose Toxicity, Toxicokinetics, and Immunogenicity of Efsubaglutide Alfa Following Subcutaneous Administration in Cynomolgus Monkeys.

40-Week Repeat-Dose Toxicity, Toxicokinetics, and Immunogenicity of Efsubaglutide Alfa Following Subcutaneous Administration in Cynomolgus Monkeys.

Journal: Regulatory toxicology and pharmacology : RTP
Published: May 21, 2026

GABA induces myokine irisin release from skeletal muscle.

GABA induces myokine irisin release from skeletal muscle.

Journal: Life sciences
Published: October 31, 2025

Trace-Cobalt Surface Engineering of Ni-Rich Co-Free Cathodes Unlocks High-Power Density and Long-Cycle Life in Pouch-Type Li-Ion Batteries.

Trace-Cobalt Surface Engineering of Ni-Rich Co-Free Cathodes Unlocks High-Power Density and Long-Cycle Life in Pouch-Type Li-Ion Batteries.

Journal: ACS nano
Published: October 16, 2025

Efsubaglutide Alfa attenuates metabolic dysfunction-associated steatohepatitis in mice with improvements in second harmonic generation-derived fibrosis features.

Efsubaglutide Alfa attenuates metabolic dysfunction-associated steatohepatitis in mice with improvements in second harmonic generation-derived fibrosis features.

Journal: Diabetes, obesity & metabolism
Published: October 10, 2025

Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.

Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.

Journal: The Journal of clinical endocrinology and metabolism
Published: February 19, 2025

GABA ameliorates diet-induced hepatic steatosis and insulin resistance by inhibiting macrophage activation.

GABA ameliorates diet-induced hepatic steatosis and insulin resistance by inhibiting macrophage activation.

Journal: Diabetes, obesity & metabolism
Published: February 19, 2025

Irisin Alleviates Impaired Mitochondrial Fusion via Enhancing PKA/SIRT3/mTOR Pathway in Hepatic Steatosis.

Irisin Alleviates Impaired Mitochondrial Fusion via Enhancing PKA/SIRT3/mTOR Pathway in Hepatic Steatosis.

Journal: Journal of gastroenterology and hepatology
Published: December 29, 2024

Klotho protects INS-1 pancreatic β-cells from senescence and enhances mitochondrial function.

Klotho protects INS-1 pancreatic β-cells from senescence and enhances mitochondrial function.

Journal: Frontiers in aging
Published: October 16, 2024

Interleukin-37 promotes wound healing in diabetic mice by inhibiting the MAPK/NLRP3 pathway.

Interleukin-37 promotes wound healing in diabetic mice by inhibiting the MAPK/NLRP3 pathway.

Journal: Journal of diabetes investigation
Published: July 16, 2024

Irisin alleviates hepatic steatosis by activating the autophagic SIRT3 pathway.

Irisin alleviates hepatic steatosis by activating the autophagic SIRT3 pathway.

Journal: Chinese medical journal
Published: July 07, 2024

Supaglutide alleviates hepatic steatosis in monkeys with spontaneous MASH.

Supaglutide alleviates hepatic steatosis in monkeys with spontaneous MASH.

Journal: Diabetology & metabolic syndrome
Published: June 29, 2024

Early identification of postoperative remission for thyrotropin-secreting adenomas.

Early identification of postoperative remission for thyrotropin-secreting adenomas.

Journal: Clinical endocrinology
Published: December 16, 2023
Showing 1-12 of 24

Last Updated: 09/26/2026